|
Product No. |
Product Name |
Size |
| BV-1001-200 |
Annexin V-FITC |
200 Assays |
| BV-1001-1000 |
Annexin V-FITC |
1000 Assays |
| BV-1002-200 |
Annexin V-Cy3 |
200 Assays |
| BV-1002-1000 |
Annexin V-Cy3 |
1000 Assays |
| BV-1003-100 |
Annexin V-Biotin |
100 ug |
| BV-1004-200 |
Annexin V-EGFP |
200 Assays |
| BV-1004-1000 |
Annexin V-EGFP |
1000 Assays |
| BV-1005-100 |
Annexin V |
100 ug |
| BV-1006-100 |
Annexin V Binding Buffer (10x) |
100 ml |
| BV-1007-1000 |
Caspase-3 Substrate, Ac-DEVD-AFC |
1000 Assays |
| BV-1007-200 |
Caspase-3 Substrate, Ac-DEVD-AFC |
200 Assays |
| BV-1008-1000 |
Caspase-3 Substrate, Ac-DEVD-pNA |
1000 Assays |
| BV-1008-200 |
Caspase-3 Substrate, Ac-DEVD-pNA |
200 Assays |
| BV-1009-100 |
Caspase-3 Inhibitor, Z-DEVD-FMK, 2 mM |
100 ul |
| BV-1009-20C |
Caspase-3 Inhibitor, Z-DEVD-FMK, 10 mM |
20 ul |
| BV-1010-100 |
Caspase-Family Inhibitor, Z-VAD-FMK, 2 mM |
100 ul |
| BV-1010-20C |
Caspase-Family Inhibitor, Z-VAD-FMK, 10 mM |
20 ul |
| BV-1011-100 |
Caspase-6 Inhibitor, Z-VEID-FMK, 2 mM |
100 ul |
| BV-1011-20C |
Caspase-6 Inhibitor, Z-VEID-FMK, 10 mM |
20 ul |
| BV-1012-100 |
Caspase-1 Inhibitor, YVAD-FMK, 2 mM |
100 ul |
| BV-1012-20C |
Caspase-1 Inhibitor, YVAD-FMK, 10 mM |
20 ul |
| BV-1013-1000 |
Annexin V-Cy5 |
1000 Assays |
| BV-1013-200 |
Annexin V-Cy5 |
200 Assays |
| BV-1014-1000 |
Annexin V-PE |
1000 Assays |
| BV-1014-200 |
Annexin V-PE |
200 Assays |
| BV-1015-1000 |
Annexin V-PE-Cy5 |
1000 Assays |
| BV-1015-200 |
Annexin V-PE-Cy5 |
200 Assays |
| BV-1035-100 |
Annexin V Binding Buffer (1x) |
100 ml |
| BV-1036-50 |
Actinomycin D, 10 mM |
50 ul |
| BV-1036-5MG |
Actinomycin D |
5 mg |
| BV-1039-1 |
Camptothecin, 2 mM |
1 ml |
| BV-1039-50MG |
Camptothecin |
50 mg |
| BV-1041-1 |
Cycloheximide, 100 mM |
1 ml |
| BV-1041-1G |
Cycloheximide |
1 g |
| BV-1042-1 |
Dexamethasone, 10 mM |
1 ml |
| BV-1042-1G |
Dexamethasone |
1 g |
| BV-1043-100 |
Etoposide, 100 mM |
100 ul |
| BV-1043-25MG |
Etoposide |
25 mg |
| BV-1048-010 |
Staurosporine |
100 ug |
| BV-1050-10 |
TNF-alpha (human) (rec.) |
10 ug |
| BV-1050-1000 |
TNF-alpha (human) (rec.) |
1 mg |
| BV-1050-50 |
TNF-alpha (human) (rec.) |
50 ug |
| BV-1051-10 |
TNF-alpha (mouse) (rec.) |
10 ug |
| BV-1051-20 |
TNF-alpha (mouse) (rec.) |
20 ug |
| BV-1051-1000 |
TNF-alpha (mouse) (rec.) |
1 mg |
| BV-1052-10 |
TNF-alpha (rat) (rec.) |
10 ug |
| BV-1052-20 |
TNF-alpha (rat) (rec.) |
20 ug |
| BV-1052-1000 |
TNF-alpha (rat) (rec.) |
1 mg |
| BV-1056-1 |
Propidium Iodide (1 mg/ml) |
1 ml |
| BV-1062-1000 |
Caspase-8 Fluorometric Substrate, Ac-IETD-AFC |
1000 Assays |
| BV-1062-200 |
Caspase-8 Fluorometric Substrate, Ac-IETD-AFC |
200 Assays |
| BV-1063-1000 |
Caspase-8 Colorimetric Substrate, Ac-IETD-pNA |
1000 Assays |
| BV-1063-200 |
Caspase-8 Colorimetric Substrate, Ac-IETD-pNA |
200 Assays |
| BV-1064-100 |
Caspase-8 Apoptosis Inhibitor, Z-IETD-FMK, 2 mM |
100 ul |
| BV-1064-20C |
Caspase-8 Apoptosis Inhibitor, Z-IETD-FMK, 10 mM |
20 ul |
| BV-1065-200 |
MitoCapture Incubation Buffer |
200 ml |
| BV-1066-100 |
Dilution Buffer (use with colorimetric caspase assay) |
100 ml |
| BV-1066-500 |
Dilution Buffer (use with colorimetric caspase assay) |
500 ml |
| BV-1067-100 |
Cell Lysis Buffer (lyse both tissues and cells) |
100 ml |
| BV-1067-400 |
Cell Lysis Buffer (lyse both tissues and cells) |
400 ml |
| BV-1068-20 |
Reaction Buffer (for 250 caspase assays) (2x) |
20 ml |
| BV-1068-80 |
Reaction Buffer (for 1000 caspase assays) (2x) |
80 ml |
| BV-1069-1000 |
Caspase-6 Fluorometric Substrate, Ac-VEID-AFC |
1000 Assays |
| BV-1069-200 |
Caspase-6 Fluorometric Substrate, Ac-VEID-AFC |
200 Assays |
| BV-1070-1000 |
Caspase-6 Colorimetric Substrate, Ac-VEID-pNA |
1000 Assays |
| BV-1070-200 |
Caspase-6 Colorimetric Substrate, Ac-VEID-pNA |
200 Assays |
| BV-1071-1000 |
Caspase-2 Fluorometric Substrate, Ac-VDVAD-AFC |
1000 Assays |
| BV-1071-200 |
Caspase-2 Fluorometric Substrate, Ac-VDVAD-AFC |
200 Assays |
| BV-1072-1000 |
Caspase-2 Colorimetric Substrate, Ac-VDVAD-pNA |
1000 Assays |
| BV-1072-200 |
Caspase-2 Colorimetric Substrate, Ac-VDVAD-pNA |
200 Assays |
| BV-1073-100 |
Caspase-2 Apoptosis Inhibitor, Z-VDVAD-FMK, 2 mM |
100 ul |
| BV-1073-20C |
Caspase-2 Apoptosis Inhibitor, Z-VDVAD-FMK, 10 mM |
20 ul |
| BV-1074-100 |
Caspase-9 Apoptosis Inhibitor, Z-LEHD-FMK, 2 mM |
100 ul |
| BV-1074-20C |
Caspase-9 Apoptosis Inhibitor, Z-LEHD-FMK, 10 mM |
20 ul |
| BV-1075-1000 |
Caspase-9 Fluorometric Substrate, Ac-LEHD-AFC |
1000 Assays |
| BV-1075-200 |
Caspase-9 Fluorometric Substrate, Ac-LEHD-AFC |
200 Assays |
| BV-1076-1000 |
Caspase-9 Colorimetric Substrate, Ac-LEHD-pNA |
1000 Assays |
| BV-1076-200 |
Caspase-9 Colorimetric Substrate, Ac-LEHD-pNA |
200 Assays |
| BV-1077-100 |
AFC ［7-Amino-4-trifluoromethylcoumarin］ |
100 mg |
| BV-1078-100 |
pNA ［p-Nitroaniline］ |
100 mg |
| BV-1079-100 |
Caspase-12 Inhibitor, Z-ATAD-FMK |
100 ul |
| BV-1079-20C |
Caspase-12 Inhibitor, Z-ATAD-FMK |
20 ul |
| BV-1081-100 |
Caspase-1 (active) (human) (rec.) |
100 Units |
| BV-1081-25 |
Caspase-1 (active) (human) (rec.) |
25 Units |
| BV-1082-100 |
Caspase-2 (active) (human) (rec.) |
100 Units |
| BV-1082-25 |
Caspase-2 (active) (human) (rec.) |
25 Units |
| BV-1083-100 |
Caspase-3 (active) (human) (rec.) |
100 Units |
| BV-1083-25 |
Caspase-3 (active) (human) (rec.) |
25 Units |
| BV-1083-5 |
Caspase-3 (active) (human) (rec.) |
5 ug |
| BV-1083P-5 |
Procaspase-3 (human) (rec.) |
5 ug |
| BV-1084-100 |
Caspase-4 (active) (human) (rec.) |
100 Units |
| BV-1084-25 |
Caspase-4 (active) (human) (rec.) |
25 Units |
| BV-1085-100 |
Caspase-5 (active) (human) (rec.) |
100 Units |
| BV-1085-25 |
Caspase-5 (active) (human) (rec.) |
25 Units |
| BV-1086-100 |
Caspase-6 (active) (human) (rec.) |
100 Units |
| BV-1086-25 |
Caspase-6 (active) (human) (rec.) |
25 Units |
| BV-1087-100 |
Caspase-7 (active) (human) (rec.) |
100 Units |
| BV-1087-25 |
Caspase-7 (active) (human) (rec.) |
25 Units |
| BV-1087P-5 |
Procaspase-7 (human) (rec.) |
5 ug |
| BV-1088-100 |
Caspase-8 (active) (human) (rec.) |
100 Units |
| BV-1088-25 |
Caspase-8 (active) (human) (rec.) |
25 Units |
| BV-1089-100 |
Caspase-9 (active) (human) (rec.) |
100 Units |
| BV-1089-25 |
Caspase-9 (active) (human) (rec.) |
25 Units |
| BV-1089P-50 |
Procaspase-9 (human) (rec.) |
50 ug |
| BV-1090A-100 |
Caspase-10a (active) (human) (rec.) |
100 Units |
| BV-1090A-25 |
Caspase-10a (active) (human) (rec.) |
25 Units |
| BV-1090B-100 |
Caspase-10b (active) (human) (rec.) |
100 Units |
| BV-1090B-25 |
Caspase-10b (active) (human) (rec.) |
25 Units |
| BV-1100-100 |
Caspase-5 Inhibitor, Z-WEHD-FMK, 2 mM |
100 ul |
| BV-1100-20C |
Caspase-5 Inhibitor, Z-WEHD-FMK, 10 mM |
20 ul |
| BV-1101-1000 |
Caspase-5 Substrate, Ac-WEHD-AFC |
1000 Assays |
| BV-1101-200 |
Caspase-5 Substrate, Ac-WEHD-AFC |
200 Assays |
| BV-1102-1000 |
Caspase-5 Substrate, Ac-WEHD-pNA |
1000 Assays |
| BV-1102-200 |
Caspase-5 Substrate, Ac-WEHD-pNA |
200 Assays |
| BV-1103-1000 |
Caspase-1 Substrate, Ac-YVAD-AFC |
1000 Assays |
| BV-1103-200 |
Caspase-1 Substrate, Ac-YVAD-AFC |
200 Assays |
| BV-1104-1000 |
Caspase-1 Substrate, Ac-YVAD-pNA |
1000 Assays |
| BV-1104-200 |
Caspase-1 Substrate, Ac-YVAD-pNA |
200 Assays |
| BV-1106-1000 |
Jurkat Cytosolic Extract (Uninduced) |
1 mg |
| BV-1106-400 |
Jurkat Cytosolic Extract (Uninduced) |
400 ug |
| BV-1107-1000 |
Jurkat Cytosolic Extract (Induced) |
1 mg |
| BV-1107-400 |
Jurkat Cytosolic Extract (Induced) |
400 ug |
| BV-1108-100 |
Caspase-4 Apoptosis Inhibitor, Z-LEVD-FMK, 2 mM |
100 ul |
| BV-1108-20C |
Caspase-4 Apoptosis Inhibitor, Z-LEVD-FMK, 10 mM |
20 ul |
| BV-1109-1000 |
Caspase-4 Fluorometric Substrate, Ac-LEVD-AFC |
1000 Assays |
| BV-1109-200 |
Caspase-4 Fluorometric Substrate, Ac-LEVD-AFC |
200 Assays |
| BV-1110-1000 |
Caspase-4 Colorimetric Substrate, Ac-LEVD-pNA |
1000 Assays |
| BV-1110-200 |
Caspase-4 Colorimetric Substrate, Ac-LEVD-pNA |
200 Assays |
| BV-1112-100 |
Caspase-10 Apoptosis Inhibitor, Z-AEVD-FMK, 2 mM |
100 ul |
| BV-1112-20C |
Caspase-10 Apoptosis Inhibitor, Z-AEVD-FMK, 10 mM |
20 ul |
| BV-1113-1000 |
Caspase-10 Fluorometric Substrate, Ac-AEVD-AFC |
1000 Assays |
| BV-1113-200 |
Caspase-10 Fluorometric Substrate, Ac-AEVD-AFC |
200 Assays |
| BV-1114-1000 |
Caspase-10 Colorimetric Substrate, Ac-AEVD-pNA |
1000 Assays |
| BV-1114-200 |
Caspase-10 Colorimetric Substrate, Ac-AEVD-pNA |
200 Assays |
| BV-1115-100 |
Caspase-13 Apoptosis Inhibitor, Z-LEED-FMK, 2 mM |
100 ul |
| BV-1115-20C |
Caspase-13 Apoptosis Inhibitor, Z-LEED-FMK, 10 mM |
20 ul |
| BV-1116-1000 |
Caspase-13 Fluorometric Substrate, Ac-LEED-AFC |
1000 Assays |
| BV-1116-200 |
Caspase-13 Fluorometric Substrate, Ac-LEED-AFC |
200 Assays |
| BV-1117-1000 |
Caspase-12 Fluorometric Substrate, Ac-ATAD-AFC |
1000 Assays |
| BV-1117-200 |
Caspase-12 Fluorometric Substrate, Ac-ATAD-AFC |
200 Assays |
| BV-1120-20C |
Caspase-Familiy Inhibitor, Boc-D-FMK |
20 ul |
| BV-1121-20C |
Caspase-8 Inhibitor, IETD-FMK (Biotin) |
20 ul |
| BV-1122-100 |
FMK Negative Control, Z-FA-FMK, 2 mM |
100 ul |
| BV-1122-20C |
FMK Negative Control, Z-FA-FMK, 10 mM |
20 ul |
| BV-1123-20C |
VAD-FMK, 10 mM (Biotin) |
20 ul |
| BV-1124-20C |
DEVD-FMK, 10 mM (Biotin) |
20 ul |
| BV-1125-20C |
Calpain Inhibitor, Z-LLT-FMK, 10 mM |
20 ul |
| BV-1126-20C |
Cathepsin B&L Inhibitor, Z-Phe-Phe-FMK, 10 mM |
20 ul |
| BV-1127-20C |
EMAP-II Inhibitor, Z-ASTD-FMK, 10 mM |
20 ul |
| BV-1128-20C |
Granzyme B Inhibitor, Z-AAD-CH2Cl |
20 ul |
| BV-1130-5 |
JC-1 |
5 mg |
| BV-1131-1 |
(Asp)2-Rhodamine 110 (D2R) |
1 mg |
| BV-1134-100 |
Calpain I (active) (human) |
100 ug |
| BV-1135-100 |
Cathepsin L (active) (human) |
100 ug |
| BV-1136-10 |
Histone Protein |
10 mg |
| BV-1137-100 |
HAT ［P/CAF］ (active) (rec.) |
100 ug |
| BV-1181-100 |
Caspase-1 (active) (mouse) (rec.) |
100 units |
| BV-1181-25 |
Caspase-1 (active) (mouse) (rec.) |
25 units |
| BV-1183-100 |
Caspase-3 (active) (mouse) (rec.) |
100 Units |
| BV-1183-25 |
Caspase-3 (active) (mouse) (rec.) |
25 Units |
| BV-1183P-5 |
Procaspase-3 (mouse) (rec.) |
5 ug |
| BV-1188-100 |
Caspase-8 (active) (mouse) |
100 units |
| BV-1188-25 |
Caspase-8 (active) (mouse) |
25 units |
| BV-1201-1 |
DTT (1M) |
1 ml |
| BV-1203-10 |
Ethidium Bromide (1 mg/ml) |
10 ml |
| BV-1209-10 |
Trypan Blue |
10 ml |
| BV-1211-20 |
Mounting Medium |
20 ml |
| BV-1241-1 |
L-Glutathione (oxidized form, GSSG) |
1 g |
| BV-1242-1 |
L-Glutathione (reduced form, GSSG) |
1 g |
| BV-1243-1 |
GST Protein (active) |
1 mg |
| BV-1266-100 |
CaspGLOW Wash Buffer |
100 ml |
| BV-1267-1 |
Rabbit Serum |
1 ml |
| BV-1268-100 |
Rabbit IgG |
100 ug |
| BV-1283-100 |
Caspase-3 (active) (rat) (rec.) |
100 Units |
| BV-1283-25 |
Caspase-3 (active) (rat) (rec.) |
25 Units |
| BV-1501-10 |
A23187 |
10 mg |
| BV-1505-100 |
Arachidonic acid |
100 mg |
| BV-1506-1000 |
Aurintricarboxylic acid |
1 g |
| BV-1519-1000 |
Colchicine |
1 g |
| BV-1522-100 |
Cyclosporine A |
100 mg |
| BV-1524-10 |
Daunorubicin . HCl |
10 mg |
| BV-1527-5 |
Doxorubicin . HCl |
5 mg |
| BV-1531-5 |
Forskolin |
5 mg |
| BV-1533-10 |
Genistein |
10 mg |
| BV-1533-100 |
Genistein |
100 mg |
| BV-1535-10 |
Genistin |
10 mg |
| BV-1543-025 |
Okadaic acid |
25 ug |
| BV-1544-5 |
Phorbol-12-myristate 13-acetate |
5 mg |
| BV-1548-5 |
PMSF |
5 g |
| BV-1549-10 |
Anisomycin (JNK Activators) |
10 mg |
| BV-1550-1000 |
Cisplatin |
1 g |
| BV-1551-1000 |
Tamoxifen citrate |
1 g |
| BV-1552-25 |
Betulinic acid |
25 mg |
| BV-1553-100 |
Carboplatin |
100 mg |
| BV-1554-10 |
Pifithrin-alpha |
10 mg |
| BV-1555-1000 |
GST Inhibitor-1 (Cibacron Blue F3G-A) |
1 g |
| BV-1556-1000 |
GST Inhibitor-2 (Ethacrynic acid) |
1 g |
| BV-1557-1000 |
G418 Sulfate (siRNA Vector Approved) |
1 g |
| BV-1558-1 |
Thapsigargin |
1 mg |
| BV-1559-5 |
Rosiglitazone |
5 mg |
| BV-1559-100 |
Rosiglitazone |
100 mg |
| BV-1560-5 |
Brefeldin A |
5 mg |
| BV-1561-50 |
Mifepristone |
50 mg |
| BV-1562-025 |
Calyculin A |
25 ug |
| BV-1563-1 |
FK-506 |
1 mg |
| BV-1564-1 |
Geldanamycin |
1 mg |
| BV-1565-5 |
Ionomycin (free acid) |
5 mg |
| BV-1566-5 |
Ionomycin (Calcium salt) |
5 mg |
| BV-1567-25 |
Paclitaxel |
25 mg |
| BV-1568-5 |
Rapamycin |
5 mg |
| BV-1569-01 |
Thymeleatoxin |
100 ug |
| BV-1570-5 |
Tyrphostin AG 490 |
5 mg |
| BV-1571-5 |
Tyrphostin AG 1295 |
5 mg |
| BV-1601-1 |
Apicidin (HDAC Inhibitors) |
1 mg |
| BV-1605-1 |
Scriptaid |
1 mg |
| BV-1606-1 |
Trichostatin A (HDAC Inhibitors) |
1 mg |
| BV-1607-1 |
M344 |
1 mg |
| BV-1608-100 |
Sodium 4-phenylbutyrate |
100 mg |
| BV-1609-1000 |
Sodium butyrate |
1 g |
| BV-1610-5 |
Splitomicin |
5 mg |
| BV-1641-1 |
HeLa Nuclear Extract |
1 mg |
| BV-1701-1 |
Akt Inhibitor |
1 mg |
| BV-1998-1 |
Dounce Tissue Grinder |
1 ea |
| BV-1999-1 |
Magnetic Separator |
1 ea |
| BV-2001-2500 |
Terminal Transferase (TdT) |
2500 units |
| BV-2001-500 |
Terminal Transferase (TdT) |
500 units |
| BV-2101-100 |
Sodium Chloride Solution (NaCl, 5 M) |
100 ml |
| BV-2102-100 |
SDS Solution (10% in H2O) |
100 ml |
| BV-2103-100 |
EDTA Solution (0.5 M, pH 8.0) |
100 ml |
| BV-2104-100 |
Triton X-100 Solution (10% in H2O) |
100 ml |
| BV-2105-100 |
Magnesium Chloride (MgCl2, 1 M) |
100 ml |
| BV-2106-100 |
Tris-HCl (1 M, pH 6.8) |
100 ml |
| BV-2107-100 |
Tris-HCl (1 M, pH 8.8) |
100 ml |
| BV-2108-10 |
SDS-PAGE Loading Buffer (3x) |
10 ml |
| BV-2109-100 |
Tween 20 Solution (10% in H2O) |
100 ml |
| BV-2110-10 |
Orange G Loading Buffer |
10 ml |
| BV-2111-100 |
Np-40 (10% in H2O) |
100 ml |
| BV-2113-500 |
Phosphate Buffered Saline (PBS, 1X) |
500 ml |
| BV-2115-100 |
Potassium Chloride Solution (KCl, 1 M) |
100 ml |
| BV-2118-100 |
Sodium Acetate (NaAc, 3 M, pH5.2) |
100 ml |
| BV-2119-10 |
BSA (10% in H2O) |
10 ml |
| BV-2120-100 |
Cytochrome c (95% pure, no TCA) |
100 mg |
| BV-2121-100 |
ATP (100mM) |
100 ul |
| BV-2221-10 |
Advanced Glycation Endproduct -BSA |
10 mg |
| BV-2301-1 |
PE Crystal |
1 mg |
| BV-2301-5 |
PE Crystal |
5 mg |
| BV-2301-25 |
PE Crystal |
25 mg |
| BV-2401-100 |
Jurkat Cell Lysate (untreated) |
100 ug |
| BV-2402-100 |
Jurkat Cell Lysate (Camptothecin-treated) |
100 ug |
| BV-2601-100 |
Small IntestineTissue Lysate (mouse) |
100 ug |
| BV-2701-100 |
Brain Tissue Lysate (rat) |
100 ug |
| BV-2702-100 |
Kidney Tissue Lysate (rat) |
100 ug |
| BV-2703-100 |
Heart Tissue Lysate (rat) |
100 ug |
| BV-2704-100 |
Liver Tissue Lysate (rat) |
100 ug |
| BV-2705-100 |
Thymus Tissue Lysate (rat) |
100 ug |
| BV-3001-100 |
MAb to PARP |
100 ug |
| BV-3002-100 |
PAb to PARP |
100 ug |
| BV-3002BP-50 |
Blocking Peptide for PAb to PARP (BV-3002) |
50 ug |
| BV-3003-100 |
MAb to Bcl-2 (7T) |
100 ug |
| BV-3004-100 |
MAb to Caspase-3 (human) (C33) |
100 ug |
| BV-3008-100 |
MAb to FADD (ms) |
100 ug |
| BV-3010-100 |
MAb to Caspase-7 (B4-G2) |
100 ug |
| BV-3012-100 |
MAb to NFkappaBp65 |
100 ug |
| BV-3015-100 |
PAb to Caspase-3 (active) |
100 ug |
| BV-3015BP-50 |
Blocking Peptide for PAb to Caspase-3 (BV-3015) |
50 ug |
| BV-3016-100 |
PAb to Caspase-9 |
100 ug |
| BV-3016BP-50 |
Blocking Peptide for PAb to Caspase-9 (BV-3016) |
50 ug |
| BV-3017-100 |
PAb to Caspase-10 |
100 ug |
| BV-3017BP-50 |
Blocking Peptide for PAb to Caspase-10 (BV-3017) |
50 ug |
| BV-3018-100 |
PAb to Apaf-1 |
100 ug |
| BV-3019-100 |
PAb to Caspase-1 |
100 ug |
| BV-3019BP-50 |
Blocking Peptide for PAb to Caspase-1 (BV-3019) |
50 ug |
| BV-3020-100 |
PAb to Caspase-8 |
100 ug |
| BV-3020BP-50 |
Blocking Peptide for PAb to Caspase-8 (BV-3020) |
50 ug |
| BV-3021-100 |
PAb to Caspase-11 |
100 ug |
| BV-3021BP-50 |
Blocking Peptide for PAb to Caspase-11 (BV-3021) |
50 ug |
| BV-3023-100 |
PAb to Caspase-6 |
100 ug |
| BV-3024-100 |
PAb to Caspase-7 |
100 ug |
| BV-3024BP-50 |
Blocking Peptide for PAb to Caspase-7 (BV-3024) |
50 ug |
| BV-3025-100 |
PAb to Cytochrome c |
100 ug |
| BV-3025BP-50 |
Blocking Peptide for PAb to Cytochrome c (BV-3025) |
50 ug |
| BV-3026-100 |
MAb to Cytochrome c |
100 ug |
| BV-3027-100 |
PAb to Caspase-2 |
100 ug |
| BV-3027BP-50 |
Blocking Peptide for PAb to Caspase-2 (BV-3027) |
50 ug |
| BV-3028-100 |
PAb to Caspase-4 |
100 ug |
| BV-3028BP-50 |
Blocking Peptide for PAb to Caspase-4 (BV-3028) |
50 ug |
| BV-3029-100 |
PAb to Caspase-5 |
100 ug |
| BV-3029BP-50 |
Blocking Peptide for PAb to Caspase-5 (BV-3029) |
50 ug |
| BV-3030-100 |
PAb to Bad |
100 ug |
| BV-3031-100 |
PAb to Bak |
100 ug |
| BV-3032-100 |
PAb to Bax |
100 ug |
| BV-3032BP-50 |
Blocking Peptide for PAb to Bax (BV-3032) |
50 ug |
| BV-3033-100 |
PAb to Bcl-2 |
100 ug |
| BV-3033BP-50 |
Blocking Peptide for PAb to Bcl-2 (BV-3033) |
50 ug |
| BV-3034-100 |
PAb to Bcl-w |
100 ug |
| BV-3035-100 |
PAb to Mcl-1 |
100 ug |
| BV-3035BP-50 |
Blocking Peptide for PAb to Mcl-1 (BV-3035) |
50 ug |
| BV-3036-100 |
MAb to p53 |
100 ug |
| BV-3037-100 |
PAb to RAIDD |
100 ug |
| BV-3038-100 |
PAb to NFkappaBp65 |
100 ug |
| BV-3038BP-50 |
Blocking Peptide for PAb to NFkappaBp65 (BV-3038) |
50 ug |
| BV-3039-100 |
PAb to FADD |
100 ug |
| BV-3039BP-50 |
Blocking Peptide for PAb to FADO (BV-3039) |
50 ug |
| BV-3041-100 |
PAb to Bcl-x |
100 ug |
| BV-3042-100 |
PAb to Bid Goat |
100 ug |
| BV-3043-100 |
PAb to Bok |
100 ug |
| BV-3044-100 |
PAb to PBR |
100 ug |
| BV-3044BP-50 |
Blocking Peptide for PAb to PBR (BV-3044) |
50 ug |
| BV-3045-100 |
PAb to TRAIL |
100 ug |
| BV-3046-100 |
MAb to Lamin B1 (2L-5) |
100 ug |
| BV-3047-100 |
PAb to DFF45 (human) |
100 ug |
| BV-3048-100 |
PAb to DFF45 |
100 ug |
| BV-3049-100 |
PAb to DFF40 |
100 ug |
| BV-3050-100 |
MAb to DFF45 (human) |
100 ug |
| BV-3051-100 |
MAb to Caspase-8 (human) (C51S) |
100 ug |
| BV-3053-100 |
PAb to TNF-alpha (mouse) |
100 ug |
| BV-3054-100 |
PAb to TNF-alpha (rabbit) |
100 ug |
| BV-3055-100 |
MAb to TNF-alpha |
100 ug |
| BV-3057-100 |
PAb to DR3/Apo3 |
100 ug |
| BV-3058-100 |
PAb to c-FLIP |
100 ug |
| BV-3060-100 |
PAb to DcR2 |
100 ug |
| BV-3061-100 |
PAb to DR4 |
100 ug |
| BV-3062-100 |
PAb to DR5 |
100 ug |
| BV-3062BP-50 |
Blocking Peptide for PAb to DR5 (BV-3062) |
50 ug |
| BV-3066-100 |
PAb to MADD |
100 ug |
| BV-3067-100 |
PAb to SHPS-1/SIRP-1alpha |
100 ug |
| BV-3069-100 |
PAb to Zip Kinase |
100 ug |
| BV-3070-100 |
PAb to Fas/Apo1 |
100 ug |
| BV-3071-100 |
PAb to CD27 |
100 ug |
| BV-3072-100 |
PAb to CD40 |
100 ug |
| BV-3073-100 |
MAb to Granzyme B (B18.1) |
100 ug |
| BV-3075-100 |
PAb to Calcineurin A |
100 ug |
| BV-3076-100 |
MAb to Calreticulin |
100 ug |
| BV-3077-100 |
PAb to Calreticulin |
100 ug |
| BV-3080-100 |
PAb to Cdc42/Rac |
100 ug |
| BV-3084-100 |
PAb to Cytochrome p450 |
100 ug |
| BV-3085-100 |
PAb to Erk1/2 (MAPK) |
100 ug |
| BV-3092-100 |
PAb to Hsp27 |
100 ug |
| BV-3094-100 |
MAb to Hsp60 (LK-1) |
100 ug |
| BV-3095-100 |
PAb to Hsc70 |
100 ug |
| BV-3095BP-50 |
Blocking Peptide for PAb to Hsc70 (BV-3095) |
50 ug |
| BV-3096-100 |
MAb to Hsp70 (S5) |
100 ug |
| BV-3097-100 |
PAb to Hsp70 |
100 ug |
| BV-3097BP-50 |
Blocking Peptide for PAb to Hsp70 (BV-3097) |
50 ug |
| BV-3098-100 |
MAb to Hsp90 (S88) |
100 ug |
| BV-3100-100 |
PAb to MAPKAPK-2 |
100 ug |
| BV-3111-100 |
PAb to Mek1 |
100 ug |
| BV-3114-100 |
PAb to p38 MAP Kinase |
100 ug |
| BV-3114BP-50 |
Blocking Peptide for PAb to p38 MAP Kinase (BV-3114) |
50 ug |
| BV-3115-100 |
PAb to PKA |
100 ug |
| BV-3115BP-50 |
Blocking Peptide for PAb to PKA (BV-3115) |
50 ug |
| BV-3116-100 |
PAb to Raf1 |
100 ug |
| BV-3116BP-50 |
Blocking Peptide for PAb to Raf1 (BV-3116) |
50 ug |
| BV-3120-100 |
PAb to Wee1 |
100 ug |
| BV-3120BP-50 |
Blocking Peptide for PAb to Wee1 (BV-3120) |
50 ug |
| BV-3123-100 |
PAb to Daxx |
100 ug |
| BV-3124-100 |
PAb to Bim/Bod |
100 ug |
| BV-3125-100 |
PAb to TNF-R1 |
100 ug |
| BV-3125BP-50 |
Blocking Peptide for PAb to TNF-R1 (BV-3125) |
50 ug |
| BV-3126-100 |
MAb to 14-3-3 |
100 ug |
| BV-3127-100 |
PAb to ARC |
100 ug |
| BV-3128-100 |
PAb to ASK1/MAKKK5 |
100 ug |
| BV-3130-100 |
PAb to DNA-PK |
100 ug |
| BV-3131-100 |
PAb to IRAK |
100 ug |
| BV-3132-100 |
PAb to RICK |
100 ug |
| BV-3133-100 |
PAb to Stat1alpha |
100 ug |
| BV-3135-100 |
PAb to Caspase-7 |
100 ug |
| BV-3135BP-50 |
Blocking Peptide for PAb to Caspase-7 (BV- 3135) |
50 ug |
| BV-3136-100 |
PAb to Caspase-9 |
100 ug |
| BV-3136BP-50 |
Blocking Peptide for PAb to Caspase-9 (BV-3136) |
50 ug |
| BV-3138-100 |
PAb to Caspase-3 |
100 ug |
| BV-3138BP-50 |
Blocking Peptide for PAb to Caspase-3 (BV-3138) |
50 ug |
| BV-3140-100 |
PAb to PARP (cleaved) (rabbit) |
100 ug |
| BV-3141-100 |
PAb to PARP (cleaved) (mouse) |
100 ug |
| BV-3142-100 |
PAb to PARP (cleaved) (rat) |
100 ug |
| BV-3147-100 |
PAb to Caspase-7 (active) |
100 ug |
| BV-3149-100 |
PAb to Caspase-9 (active) (human) |
100 ug |
| BV-3151-100 |
PAb to Caspase-9 (active) (rat) |
100 ug |
| BV-3156-100 |
PAb to Caspase-6 (active) |
100 ug |
| BV-3158-100 |
PAb to Caspase-8 (active) (human) |
100 ug |
| BV-3158BP-50 |
Blocking Peptide for PAb to Caspase-8 (BV-3158) |
50 ug |
| BV-3160-100 |
PAb to Survivin (human) |
100 ug |
| BV-3161-100 |
PAb to Survivin (mouse) |
100 ug |
| BV-3172-100 |
PAb to Bid (rabbit) |
100 ug |
| BV-3172BP-50 |
Blocking Peptide for PAb to Bid (rabbit) (BV-3172) |
50 ug |
| BV-3173-100 |
MAb to Granzyme B (O2C5/F5) |
100 ug |
| BV-3175-100 |
PAb to BLK |
100 ug |
| BV-3176-100 |
PAb to Hrk |
100 ug |
| BV-3178-100 |
PAb to CD40L |
100 ug |
| BV-3178BP-50 |
Blocking Peptide for PAb to CD40L (BV-3178) |
50 ug |
| BV-3179-100 |
MAb to Caspase-14 (mouse) (80A1585) |
100 ug |
| BV-3180-100 |
PAb to cIAP-1/HIAP-2 |
100 ug |
| BV-3180BP-50 |
Blocking Peptide for PAb to cIAP-1 (BV-3180) |
50 ug |
| BV-3181-100 |
PAb to cIAP-2/HIAP-1 |
100 ug |
| BV-3181BP-50 |
Blocking Peptide for PAb to cIAP-2 (BV-3181) |
50 ug |
| BV-3182-100 |
PAb to Caspase-12 |
100 ug |
| BV-3182BP-50 |
Blocking Peptide for PAb to Caspase-12 (BV-3182) |
50 ug |
| BV-3183-100 |
PAb to XIAP |
100 ug |
| BV-3183BP-50 |
Blocking Peptide for PAb to XIAP (BV-3183) |
50 ug |
| BV-3184-100 |
PAb to p62dok |
100 ug |
| BV-3185-100 |
PAb to IKKalpha/IKK-1 |
100 ug |
| BV-3186-100 |
PAb to IKKbeta/IKK-2 |
100 ug |
| BV-3187-100 |
MAb to Holocytochrome c |
100 ug |
| BV-3188-100 |
MAb to Perforin |
100 ug |
| BV-3189-100 |
PAb to Calpain I |
100 ug |
| BV-3190-100 |
PAb to Cathepsin B |
100 ug |
| BV-3190BP-50 |
Blocking Peptide for PAb to Cathepsin B (BV-3190) |
50 ug |
| BV-3191-100 |
PAb to Cathepsin D |
100 ug |
| BV-3192-100 |
PAb to Cathepsin L |
100 ug |
| BV-3192BP-50 |
Blocking Peptide for PAb to Cathepsin L (BV-3192) |
50 ug |
| BV-3193-100 |
PAb to NIK |
100 ug |
| BV-3194-100 |
PAb to TrkA |
100 ug |
| BV-3195-100 |
MAb to Bcl-2 |
100 ug |
| BV-3196-100 |
PAb to Mek1 |
100 ug |
| BV-3200-100 |
PAb to Acinus |
100 ug |
| BV-3201-100 |
PAb to Adam10/Kurz |
100 ug |
| BV-3202-100 |
PAb to AIF |
100 ug |
| BV-3202BP-50 |
Blocking Peptide for PAb to AIF (BV-3202) |
50 ug |
| BV-3203-100 |
PAb to BAFF/BLyS |
100 ug |
| BV-3204-100 |
PAb to Bcl-10/CIPER/CLAP |
100 ug |
| BV-3205-100 |
PAb to Bnip3L |
100 ug |
| BV-3207-100 |
PAb to Caspase-13 |
100 ug |
| BV-3209-100 |
PAb to CIDE-A |
100 ug |
| BV-3210-100 |
PAb to CIDE-A |
100 ug |
| BV-3211-100 |
PAb to CIDE-B |
100 ug |
| BV-3212-100 |
PAb to DcR1 |
100 ug |
| BV-3213-100 |
PAb to DcR3 |
100 ug |
| BV-3214-100 |
PAb to Dnase I |
100 ug |
| BV-3215-100 |
PAb to DNase II |
100 ug |
| BV-3216-100 |
PAb to DR6 |
100 ug |
| BV-3217-100 |
PAb to DRAK1 |
100 ug |
| BV-3218-100 |
PAb to DRAK2 |
100 ug |
| BV-3219-100 |
PAb to FLASH |
100 ug |
| BV-3220-100 |
PAb to IRAK-2 |
100 ug |
| BV-3221-100 |
PAb to SODD |
100 ug |
| BV-3222-100 |
PAb to TACE |
100 ug |
| BV-3228-100 |
PAb to NAIP |
100 ug |
| BV-3230-100 |
MAb to Cathepsin L |
100 ug |
| BV-3243-100 |
PAb to IL-1RAcP |
100 ug |
| BV-3244-100 |
PAb to MYD88 |
100 ug |
| BV-3247-100 |
PAb to Akt/PKB |
100 ug |
| BV-3247BP-50 |
Blocking Peptide for PAb to Akt/PKB (BV-3247) |
50 ug |
| BV-3248-100 |
PAb to PAK1 |
100 ug |
| BV-3249-100 |
PAb to Galphai2 |
100 ug |
| BV-3250-100 |
PAb to Galpha16 |
100 ug |
| BV-3251-100 |
PAb to TLR4 |
100 ug |
| BV-3252-100 |
PAb to IkappaBalpha |
100 ug |
| BV-3256-100 |
PAb to Caspase-6 |
100 ug |
| BV-3256BP-50 |
Blocking Peptide for PAb to Caspase-6 (BV-3256) |
50 ug |
| BV-3257-100 |
PAb to Akt (activated)(pSer473) |
100 ug |
| BV-3258-100 |
MAb to Caspase-8 (active) (human) (C502S) |
100 ug |
| BV-3259-100 |
PAb to Caspase-8 (active) |
100 ug |
| BV-3259BP-50 |
Blocking Peptide for PAb to Caspase-8 (active) (BV-3259) |
50 ug |
| BV-3261-100 |
PAb to DAP1 |
100 ug |
| BV-3263-100 |
PAb to DAP3 |
100 ug |
| BV-3265-100 |
PAb to DAP5 |
100 ug |
| BV-3266-100 |
PAb to alpha-Fodrin |
100 ug |
| BV-3267-100 |
PAb to Lamin A |
100 ug |
| BV-3267BP-50 |
Blocking Peptide for PAb to Lamin A (BV-3267) |
50 ug |
| BV-3269-100 |
PAb to Bad (activated)(pSer112) |
100 ug |
| BV-3270-100 |
PAb to AFX (activated)(pSer193) |
100 ug |
| BV-3272-100 |
PAb to Bid |
100 ug |
| BV-3278-100 |
PAb to MSK1 (activated)(pThr581) |
100 ug |
| BV-3279-100 |
PAb to RIP |
100 ug |
| BV-3280-100 |
PAb to RGS3 |
100 ug |
| BV-3282-100 |
PAb to Caspase-12 |
100 ug |
| BV-3282BP-50 |
Blocking Peptide for PAb to Caspase-12 (BV-3282) |
50 ug |
| BV-3285-100 |
PAb to MKK3 |
100 ug |
| BV-3287-100 |
PAb to Perforin |
100 ug |
| BV-3291-100 |
PAb to ASC |
100 ug |
| BV-3292-100 |
PAb to APRIL |
100 ug |
| BV-3293-100 |
PAb to RIP3 |
100 ug |
| BV-3294-100 |
PAb to PID |
100 ug |
| BV-3295-100 |
PAb to p53R2 |
100 ug |
| BV-3296-100 |
PAb to NAK/TBK1 |
100 ug |
| BV-3297-100 |
PAb to MTBP |
100 ug |
| BV-3298-100 |
PAb to Smac/DIABLO |
100 ug |
| BV-3300-100 |
PAb to IRAK-M |
100 ug |
| BV-3301-100 |
PAb to IKKgamma |
100 ug |
| BV-3302-100 |
PAb to IKKepsilon |
100 ug |
| BV-3303-100 |
PAb to DAP Kinase 2 |
100 ug |
| BV-3304-100 |
PAb to F1Aalpha |
100 ug |
| BV-3305-100 |
PAb to Chk2 |
100 ug |
| BV-3311-100 |
PAb to RasGAP |
100 ug |
| BV-3311BP-50 |
Blocking Peptide for PAb to RasGAP (BV-3311) |
50 ug |
| BV-3312-100 |
PAb to Bcl-xL |
100 ug |
| BV-3312BP-50 |
Blocking Peptide for PAb to Bcl-xL (BV-3312) |
50 ug |
| BV-3313-100 |
PAb to DEDAF |
100 ug |
| BV-3314-100 |
PAb to CIKS/Act1 |
100 ug |
| BV-3315-100 |
MAb to IkappaBalpha |
100 ug |
| BV-3322-100 |
MAb to Caspase-2 (human) (B22) |
100 ug |
| BV-3328-100 |
MAb to Caspase-4 (human) (D44) |
100 ug |
| BV-3330-100 |
MAb to FasL |
100 ug |
| BV-3331-100 |
MAb to Bax |
100 ug |
| BV-3332-100 |
PAb to ARTS |
100 ug |
| BV-3334-100 |
PAb to Bmf |
100 ug |
| BV-3335-100 |
PAb to CARD9 |
100 ug |
| BV-3336-100 |
PAb to EndoG |
100 ug |
| BV-3337-100 |
PAb to ILP-2 |
100 ug |
| BV-3338-100 |
PAb to Livin |
100 ug |
| BV-3339-100 |
PAb to PUMA |
100 ug |
| BV-3340-100 |
PAb to p53DINP1 |
100 ug |
| BV-3341-100 |
PAb to PERP |
100 ug |
| BV-3342-100 |
PAb to Oct-1 |
100 ug |
| BV-3342BP-50 |
Blocking Peptide for PAb to Oct-1 (BV-3342) |
50 ug |
| BV-3343-100 |
MAb to FADD |
100 ug |
| BV-3345-100 |
PAb to FasL |
100 ug |
| BV-3346-100 |
PAb to FAF1 |
100 ug |
| BV-3347R-100 |
PAb to BI-1 |
100 ug |
| BV-3347BP-50 |
Blocking Peptide for PAb to BI-1 (BV-3347) |
50 ug |
| BV-3348-100 |
PAb to TANK |
100 ug |
| BV-3348BP-50 |
Blocking Peptide for PAb to TANK (BV-3348) |
50 ug |
| BV-3349-100 |
PAb to ILP-2 |
100 ug |
| BV-3350-100 |
PAb to PCNA |
100 ug |
| BV-3350R-100 |
PAb to PCNA |
100 ug |
| BV-3351-100 |
PAb to Mek2 |
100 ug |
| BV-3352-100 |
PAb to Cytochrome c (rat) |
100 ug |
| BV-3352BP-50 |
Blocking Peptide for PAb to Cytochrome c (rat) (BV-3352) |
50 ug |
| BV-3353-100 |
PAb to Cytochrome c |
100 ug |
| BV-3353BP-50 |
Blocking Peptide for PAb to Cytochrome c (BV-3353) |
50 ug |
| BV-3354-100 |
PAb to NF-kappaB p50 |
100 ug |
| BV-3355-100 |
PAb to ALK |
100 ug |
| BV-3356-100 |
PAb to beta-Amyloid |
100 ug |
| BV-3357-100 |
PAb to Annexin V |
100 ug |
| BV-3357BP-50 |
Blocking Peptide for PAb to Annexin V (BV-3357) |
50 ug |
| BV-3358-100 |
PAb to ATF-2 |
100 ug |
| BV-3359-100 |
PAb to ATF-2 (activated) |
100 ug |
| BV-3360-200 |
PAb to CREB |
200 ul |
| BV-3361-100 |
PAb to Cox-1 |
100 ug |
| BV-3361BP-50 |
Blocking Peptide for PAb to Cox-1 (BV-3361) |
50 ug |
| BV-3362-100 |
PAb to Cox-2 |
100 ug |
| BV-3362BP-50 |
Blocking Peptide for PAb to Cox-2 (BV-3362) |
50 ug |
| BV-3363-100 |
PAb to BLCAM |
100 ug |
| BV-3364-100 |
PAb to BRCA1 |
100 ug |
| BV-3365R-100 |
PAb to Cadherin |
100 ug |
| BV-3365RBP-50 |
Blocking Peptide for PAb to Cadherin (BV-3365R) |
50 ug |
| BV-3366-100 |
PAb to Cathepsin S |
100 ug |
| BV-3366R-100 |
PAb to Cathepsin S (human) |
100 ug |
| BV-3366RBP-50 |
Blocking Peptide for PAb to Cathepsin S (human) (BV-3366R) |
50 ug |
| BV-3367-100 |
PAb to Cathepsin H |
100 ug |
| BV-3368-100 |
PAb to Cathepsin K |
100 ug |
| BV-3368BP-50 |
Blocking Peptide for PAb to Cathepsin K (BV-3368) |
50 ug |
| BV-3369-200 |
PAb to Cathepsin P |
200 ul |
| BV-3370-200 |
PAb to Cathepsin G |
200 ul |
| BV-3371-100 |
PAb to Cathepsin F |
100 ul |
| BV-3372-100 |
PAb to Calpain 2 |
100 ul |
| BV-3373-100 |
PAb to Calpain 3 |
100 ul |
| BV-3375-100 |
PAb to Calpain 5 |
100 ul |
| BV-3376-100 |
PAb to Calpain 6 |
100 ul |
| BV-3377-100 |
PAb to Calpain 7 |
100 ul |
| BV-3380-100 |
PAb to beta-Catenin |
100 ug |
| BV-3381-100 |
PAb to beta-Catenin (activated) |
100 ug |
| BV-3383-100 |
PAb to CaMKII |
100 ug |
| BV-3384-100 |
PAb to CaMKII (activated) |
100 ug |
| BV-3385-100 |
PAb to D4-GDI |
100 ug |
| BV-3386-100 |
PAb to DARPP-32 |
100 ug |
| BV-3387-100 |
PAb to Elk-1 |
100 ug |
| BV-3388-100 |
PAb to Elk-1 (phosphorylated) |
100 ug |
| BV-3389-100 |
PAb to HSP90 |
100 ug |
| BV-3389BP-50 |
Blocking Peptide for PAb to HSP90 (BV-3389) |
50 ug |
| BV-3390-100 |
PAb to HSP105 |
100 ug |
| BV-3390BP-50 |
Blocking Peptide for PAb to HSP105 (BV-3390) |
50 ug |
| BV-3391-100 |
PAb to Heme Oxygenase-1 |
100 ug |
| BV-3392-100 |
PAb to Heme Oxygenase-2 |
100 ug |
| BV-3393-100 |
PAb to HCAM |
100 ug |
| BV-3393BP-50 |
Blocking Peptide for PAb to HCAM (BV-3393) |
50 ug |
| BV-3394-100 |
PAb to GRK2 |
100 ug |
| BV-3395-100 |
PAb to GRB2 |
100 ul |
| BV-3396-100 |
PAb to Endostatin |
100 ul |
| BV-3397-100 |
PAb to Erk5 |
100 ug |
| BV-3398-100 |
PAb to Etk |
100 ug |
| BV-3399-100 |
PAb to FAK |
100 ug |
| BV-3400-100 |
PAb to FAK (activated) |
100 ug |
| BV-3401-100 |
PAb to A1 |
100 ug |
| BV-3401BP-50 |
Blocking Peptide for PAb to A1 (BV-3401) |
50 ug |
| BV-3402-100 |
PAb to ABIN-2 |
100 ug |
| BV-3403-100 |
PAb to ACT1 |
100 ug |
| BV-3404-100 |
PAb to AFX |
100 ug |
| BV-3405-100 |
PAb to APE-1 |
100 ug |
| BV, -3406-100 |
PAb to APEXL2 |
100 ug |
| BV-3407-100 |
PAb to Bcl-3 |
100 ug |
| BV-3408-100 |
PAb to Bcl-6 |
100 ug |
| BV-3409-100 |
PAb to Caspase-9 |
100 ug |
| BV-3409BP-50 |
Blocking Peptide for PAb to Caspase-9 (BV-3409) |
50 ug |
| BV-3410-200 |
PAb to Caspase-10 |
200 ug |
| BV-3410BP-50 |
Blocking Peptide for PAb to Caspase-10 (BV-3410) |
50 ug |
| BV-3411-100 |
MAb to Cathepsin V |
100 ug |
| BV-3411BP-50 |
Blocking Peptide for MAb to Cathepsin V (BV-3411) |
50 ug |
| BV-3412-100 |
MAb to Cathepsin W |
100 ug |
| BV-3413-100 |
PAb to CETP |
100 ug |
| BV-3413BP-50 |
Blocking Peptide for PAb to CETP (BV-3413) |
50 ug |
| BV-3414-100 |
PAb to CCR1 |
100 ug |
| BV-3415-100 |
PAb to CCR2 |
100 ug |
| BV-3416-100 |
PAb to CCR3 |
100 ug |
| BV-3417-100 |
PAb to CCR4 |
100 ug |
| BV-3419-100 |
PAb to CXCR5 |
100 ug |
| BV-3419BP-50 |
Blocking Peptide for PAb to CXCR5 (BV-3419) |
50 ug |
| BV-3420-100 |
PAb to FAST |
100 ug |
| BV-3421-100 |
PAb to GADD153 |
100 ug |
| BV-3421BP-50 |
Blocking Peptide for PAb to DADD153 (BV-3421) |
50 ug |
| BV-3422-100 |
PAb to ICAM-1 |
100 ug |
| BV-3423-100 |
PAb to ILK1 |
100 ug |
| BV-3424-100 |
PAb to IRS-1 |
100 ug |
| BV-3425-100 |
PAb to NPM |
100 ug |
| BV-3426-100 |
PAb to eNOS |
100 ug |
| BV-3427-100 |
PAb to nNOS |
100 ug |
| BV-3428-100 |
PAb to Neurexin |
100 ul |
| BV-3429-100 |
PAb to MSH2 |
100 ug |
| BV-3430-100 |
PAb to MLK3 |
100 ug |
| BV-3431-100 |
PAb to MLK3 (activated) |
100 ug |
| BV-3432-100 |
PAb to MLH1 |
100 ug |
| BV-3433-100 |
PAb to LIMK1 |
100 ug |
| BV-3434-100 |
PAb to MAPKAPK-2 (activated) |
100 ug |
| BV-3435-100 |
PAb to Mek5 |
100 ug |
| BV-3436-100 |
PAb to Mek6 |
100 ug |
| BV-3438-100 |
PAb to p38 (activated) |
100 ug |
| BV-3440-100 |
PAb to uPAR |
100 ug |
| BV-3441-100 |
PAb to Erk1/2 (activated) |
100 ug |
| BV-3442-100 |
PAb to Erk2 |
100 ug |
| BV-3443-100 |
PAb to PAK2 |
100 ug |
| BV-3443BP-50 |
Blocking Peptide for PAb to PAK2 (BV-3443) |
50 ug |
| BV-3444-100 |
PAb to PAK4 |
100 ug |
| BV-3445-100 |
PAb to TLR3 |
100 ul |
| BV-3446-100 |
PAb to TLR1 |
100 ul |
| BV-3447-100 |
PAb to PAR4 |
100 ug |
| BV-3448-100 |
PAb to Paxillin |
100 ug |
| BV-3449-100 |
PAb to PDK1 |
100 ug |
| BV-3450-100 |
PAb to PKC |
100 ug |
| BV-3451-100 |
PAb to PKC (activated) |
100 ug |
| BV-3452-100 |
PAb to PKG |
100 ug |
| BV-3453-100 |
MAb to Tau-13 |
100 ul |
| BV-3454-100 |
PAb to TAJ/TROY |
100 ug |
| BV-3455-100 |
PAb to PMS2 |
100 ug |
| BV-3455BP-50 |
Blocking Peptide for PAb to PMS2 (BV-3455) |
50 ug |
| BV-3456-100 |
PAb to PPARgamma |
100 ug |
| BV-3457-100 |
PAb to Syk |
100 ug |
| BV-3458-100 |
PAb to SOD-1 |
100 ug |
| BV-3459-100 |
PAb to SGK |
100 ug |
| BV-3460-100 |
PAb to SHP-2 |
100 ug |
| BV-3461-100 |
PAb to Smad1 |
100 ug |
| BV-3462-100 |
PAb to Smad2 |
100 ug |
| BV-3463-100 |
PAb to Smad3 |
100 ug |
| BV-3464-100 |
PAb to Smad4 |
100 ug |
| BV-3465-100 |
PAb to Smad5 |
100 ug |
| BV-3466-100 |
PAb to Smad6 |
100 ug |
| BV-3467-100 |
PAb to Stat1 (activated) |
100 ug |
| BV-3468-100 |
PAb to Stat2 |
100 ug |
| BV-3469-100 |
PAb to Stat2 (activated) |
100 ug |
| BV-3470-100 |
PAb to Stat3 |
100 ug |
| BV-3471-100 |
PAb to Stat4 |
100 ug |
| BV-3472-100 |
PAb to Stat5 |
100 ug |
| BV-3473-100 |
PAb to Stat6 |
100 ug |
| BV-3474-100 |
PAb to Stat3 (activated) |
100 ug |
| BV-3475-100 |
PAb to Stat5 (activated) |
100 ug |
| BV-3476-100 |
PAb to Stat6 (activated) |
100 ug |
| BV-3477-100 |
PAb to JKK/SEK1/MKK4 |
100 ug |
| BV-3478-100 |
PAb to JKK/SEK1/MKK4 (activated) |
100 ug |
| BV-3479-100 |
PAb to PTEN |
100 ug |
| BV-3480-100 |
PAb to Rad1 |
100 ug |
| BV-3481-100 |
PAb to Presenilin 1 |
100 ug |
| BV-3482-100 |
PAb to Presenilin 2 |
100 ug |
| BV-3483-100 |
PAb to Rab5 |
100 ug |
| BV-3483BP-50 |
Blocking Peptide for PAb to Rab5 (BV-3483) |
50 ug |
| BV-3484-100 |
PAb to Rab17 |
100 ug |
| BV-3485-100 |
PAb to p70 S6 Kinase |
100 ug |
| BV-3486-100 |
MAb to Cystatin A |
100 ug |
| BV-3487-100 |
MAb to Cystatin B |
100 ug |
| BV-3488-100 |
PAb to Dnmt2 |
100 ug |
| BV-3489-100 |
PAb to EG-VEGF |
100 ul |
| BV-3490-100 |
PAb to FIAF |
100 ug |
| BV-3491-100 |
PAb to Fis 1 |
100 ul |
| BV-3492-100 |
PAb to Grim 19 |
100 ug |
| BV-3493-100 |
PAb to GSK-3alpha |
100 ug |
| BV-3494-100 |
PAb to GSK-3beta |
100 ug |
| BV-3495-100 |
PAb to GSK-3beta (activated) |
100 ug |
| BV-3496-100 |
PAb to Hsp47 |
100 ug |
| BV-3496BP-50 |
Blocking Peptide for PAb to Hsp47 (BV-3496) |
50 ug |
| BV-3497-100 |
PAb to HtrA2/Omi |
100 ug |
| BV-3498-100 |
PAb to Lck |
100 ug |
| BV-3498BP-50 |
Blocking Peptide for PAb to Lck (BV-3498) |
50 ug |
| BV-3499-100 |
PAb to Lck (activated) |
100 ug |
| BV-3501-100 |
PAb to c-Myc (activated)(pThr58/pSer62) |
100 ug |
| BV-3502-100 |
PAb to c-Jun (activated)(pSer73) |
100 ug |
| BV-3503-100 |
PAb to TrkA (activated)(pTyr490) |
100 ug |
| BV-3504-100 |
PAb to Raf (activated)(pSer259) |
100 ug |
| BV-3505-100 |
PAb to p70 S6 Kinase (activated) |
100 ug |
| BV-3515-100 |
PAb to p53 (activated)(pSer15) |
100 ug |
| BV-3516-100 |
PAb to GSK-3alpha (activated) |
100 ug |
| BV-3517-100 |
PAb to MBD4 |
100 ug |
| BV-3518-100 |
PAb to Mek1/2 |
100 ul |
| BV-3519-100 |
PAb to Mek1/2 (activated) |
100 ul |
| BV-3520-100 |
PAb to MLN64 |
100 ug |
| BV-3522-100 |
PAb to MMP-2 |
100 ug |
| BV-3523-100 |
PAb to MMP-3 |
100 ug |
| BV-3523R-100 |
PAb to MMP-3 |
100 ug |
| BV-3523RBP-50 |
Blocking Peptide for PAb to MMP-3 (BV-3523R) |
50 ug |
| BV-3528-100 |
PAb to MMP-8 |
100 ug |
| BV-3529-100 |
PAb to MMP-9 |
100 ug |
| BV-3531-100 |
PAb to MMP-11 |
100 ug |
| BV-3532R-100 |
PAb to MMP-12 |
100 ug |
| BV-3532RBP-50 |
Blocking Peptide for PAb to MMP-12 (BV-3532R) |
50 ug |
| BV-3533-100 |
PAb to MMP-13 |
100 ug |
| BV-3534-100 |
PAb to MMP-24 |
100 ug |
| BV-3537-100 |
PAb to MMP-17 |
100 ug |
| BV-3540-100 |
PAb to TIA-1 |
100 ug |
| BV-3541-100 |
PAb to NSF |
100 ug |
| BV-3541BP-50 |
Blocking Peptide for PAb to NSF (BV-3541) |
50 ug |
| BV-3542-100 |
PAb to p42/44 MAPK |
100 ug |
| BV-3543-100 |
PAb to Perilipin A |
100 ug |
| BV-3544-100 |
MAb to Proteinase Inhibitor 9 (P-I9) |
100 ug |
| BV-3544BP-50 |
Blocking Peptide for Mab to Proteinase Inhibitor 9 (P-I9) (BV-3544) |
50 ug |
| BV-3545-100 |
MAb to ROCK-1 (cleaved) |
100 ug |
| BV-3546-100 |
PAb to RSK2 |
100 ug |
| BV-3547-100 |
PAb to TACI |
100 ug |
| BV-3548-100 |
PAb to TAK-1 |
100 ug |
| BV-3549-100 |
PAb to Tau |
100 ug |
| BV-3550-100 |
PAb to Tau (activated) |
100 ug |
| BV-3552-100 |
PAb to TLR2 |
100 ul |
| BV-3555-100 |
PAb to TLR5 |
100 ul |
| BV-3556-100 |
PAb to TLR6 |
100 ul |
| BV-3557-100 |
PAb to TLR7 |
100 ul |
| BV-3558-100 |
MAb to TLR8 |
100 ul |
| BV-3559-100 |
PAb to TLR9 |
100 ul |
| BV-3560-100 |
PAb to TMS1 |
100 ug |
| BV-3561-100 |
PAb to TRADD |
100 ug |
| BV-3561BP-50 |
Blocking Peptide for PAb to TRADD (BV-3561) |
50 ug |
| BV-3563-100 |
PAb to TRAF3 |
100 ug |
| BV-3564-100 |
PAb to TweakR |
100 ug |
| BV-3565-100 |
PAb to VEGF-D |
100 ug |
| BV-3566-100 |
PAb to TRAF6 |
100 ug |
| BV-3567-100 |
PAb to cAMP |
100 ul |
| BV-3568-100 |
PAb to cGMP |
100 ul |
| BV-3569-100 |
MAb to TLR2 |
100 ul |
| BV-3572R-100 |
PAb to Wnt-2 |
100 ug |
| BV-3572BP-50 |
Blocking Peptide for PAb to Wnt-2 (BV-3572) |
50 ug |
| BV-3574R-100 |
PAb to Wnt-4 |
100 ug |
| BV-3574BP-50 |
Blocking Peptide for PAb to Wnt-4 (BV-3574) |
50 ug |
| BV-3575-100 |
PAb to Oct-2 |
100 ug |
| BV-3576-100 |
PAb to Oct-4 |
100 ug |
| BV-3576BP-50 |
Blocking Peptide for PAb to Oct-4 (BV-3576) |
50 ug |
| BV-3577-100 |
PAb to BCMA |
100 ug |
| BV-3578-100 |
PAb to BAFF-R |
100 ug |
| BV-3579-100 |
PAb to DC-SIGN |
100 ug |
| BV-3580-100 |
PAb to IRAK-4 |
100 ug |
| BV-3581-100 |
PAb to PHAP I |
100 ug |
| BV-3583-100 |
PAb to PHAP III |
100 ug |
| BV-3584-100 |
PAb to LIMK2 |
100 ug |
| BV-3585-100 |
PAb to PPARalpha |
100 ug |
| BV-3586-100 |
PAb to Dystrophin |
100 ug |
| BV-3587-100 |
PAb to PLC gamma2 |
100 ug |
| BV-3587R-100 |
PAb to PLC gamma2 |
100 ug |
| BV-3587RBP-50 |
Blocking Peptide for PAb to PLC gamma2 (BV-3587R) |
50 ug |
| BV-3588-100 |
PAb to Cathepsin K |
100 ug |
| BV-3588BP-50 |
Blocking Peptide for PAb to Cathepsin K (BV-3588) |
50 ug |
| BV-3589-100 |
PAb to JNK/SAPK (activated) |
100 ug |
| BV-3590-100 |
PAb to KiSS-1 |
100 ug |
| BV-3590BP-50 |
Blocking Peptide for PAb to KiSS-1 (BV-3590) |
50 ug |
| BV-3591-100 |
PAb to Galectin-3 |
100 ug |
| BV-3591BP-50 |
Blocking Peptide for PAb to Galectin-3 (BV-3591) |
50 ug |
| BV-3592-100 |
PAb to Dio-1 |
100 ug |
| BV-3592BP-50 |
Blocking Peptide for PAb to Dio-1 (BV-3592) |
50 ug |
| BV-3593-100 |
PAb to TrkB |
100 ug |
| BV-3593BP-50 |
Blocking Peptide for PAb to TrkB (BV-3593) |
50 ug |
| BV-3594-100 |
PAb to VDAC/Porin |
100 ug |
| BV-3595-100 |
PAb to PLTP |
100 ul |
| BV-3595BP-50 |
Blocking Peptide for PAb to PLTP (BV-3595) |
50 ug |
| BV-3596-100 |
PAb to Galectin-1 |
100 ug |
| BV-3597-100 |
PAb to beta-Actin |
100 ug |
| BV-3598-100 |
MAb to beta-Actin |
100 ug |
| BV-3599-100 |
PAb to Aromatase |
100 ug |
| BV-3599BP-50 |
Blocking Peptide for PAb to Aromatase (Bv-3599) |
50 ug |
| BV-3600-100 |
PAb to Lysine (acetylated) |
100 ug |
| BV-3601-100 |
PAb to Histone Deacetylase 1 ［HDAC1］ |
100 ug |
| BV-3601BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 1 ［HDAC1］ (BV-3601) |
50 ug |
| BV-3602-100 |
PAb to Histone Deacetylase 2 ［HDAC2］ |
100 ug |
| BV-3602BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 2 ［HDAC2］ (BV-3602) |
50 ug |
| BV-3603-100 |
PAb to Histone Deacetylase 3 ［HDAC3］ |
100 ug |
| BV-3603BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 3 ［HDAC3］ (BV-3603) |
50 ug |
| BV-3604-100 |
PAb to Histone Deacetylase 4 ［HDAC4］ |
100 ug |
| BV-3604A-100 |
PAb to Histone Deacetylase 4 ［HDAC4］ |
100 ug |
| BV-3604BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 4 ［HDAC4］ (BV-3604) |
50 ug |
| BV-3605-100 |
PAb to Histone Deacetylase 5 ［HDAC5］ |
100 ug |
| BV-3605BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 5 ［HDAC5］ (BV-3605) |
50 ug |
| BV-3606-100 |
PAb to Histone Deacetylase 6 ［HDAC6］ |
100 ug |
| BV-3606BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 6 ［HDAC6］ (BV-3606) |
50 ug |
| BV-3607-100 |
PAb to Histone Deacetylase 7 ［HDAC7］ |
100 ug |
| BV-3607BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 7 ［HDAC7］ (BV-3607) |
50 ug |
| BV-3608-100 |
PAb to Histone Deacetylase 8 ［HDAC8］ |
100 ug |
| BV-3608BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 8 ［HDAC-8］ (BV-3608) |
50 ug |
| BV-3609-100 |
PAb to Histone Deacetylase 9 ［HDAC9］ |
100 ug |
| BV-3609BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 9 ［HDAC9］ (BV-3609) |
50 ug |
| BV-3610-100 |
PAb to Histone Deacetylase 10 ［HDAC10］ |
100 ug |
| BV-3610BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 10 ［HDAC10］ (BV-3610) |
50 ug |
| BV-3611P-100 |
PAb to Histone Deacetylase 11 ［HDAC11］ |
100 ug |
| Bv-3611BP-50 |
Blocking Peptide for PAb to Histone Deacetylase 11 ［HDAC11］ (BV-3611P) |
50 ug |
| BV-3621-100 |
PAb to Histone H2A |
100 ug |
| BV-3622-100 |
PAb to Histone H2B |
100 ug |
| BV-3623-100 |
PAb to Histone H3 |
100 ug |
| BV-3624-100 |
PAb to Histone H4 |
100 ug |
| BV-3630-100 |
PAb to Fibronectin |
100 ug |
| BV-3631-100 |
PAb to E-Selectin |
100 ug |
| BV-3631BP-50 |
Blocking Peptide for PAb to E-Selectin (BV-3631) |
50 ug |
| BV-3632-100 |
PAb to L-Selectin |
100 ug |
| BV-3632BP-50 |
Blocking Peptide for PAb to L-Selectin (BV-3632) |
50 ug |
| BV-3633-100 |
PAb to P-Selectin |
100 ug |
| BV-3633BP-50 |
Blocking Peptide for PAb to P-Selectin (BV-3633) |
50 ug |
| BV-3634-100 |
PAb to Vimentin |
100 ug |
| BV-3634BP-50 |
Blocking Peptide for PAb to Vimentin (BV-3634) |
50 ug |
| BV-3635-100 |
PAb to FKB12 |
100 ug |
| BV-3636-100 |
PAb to PAX6 |
100 ug |
| BV-3637R-100 |
PAb to Annexin VIII (human) |
100 ug |
| BV-3637RBP-50 |
Blocking Peptide for PAb to Annexin VIII (human) (BV-3637R) |
50 ug |
| BV-3638-100 |
PAb to COX-4 |
100 ug |
| BV-3638BP-50 |
Blocking Peptide for PAb to COX-4 (BV-3638) |
50 ug |
| BV-3640-100 |
PAb to PPARdelta |
100 ug |
| BV-3641-100 |
PAb to LXR |
100 ug |
| BV-3641BP-50 |
Blocking Peptide for PAb to LXR (BV-3641) |
50 ug |
| BV-3642-100 |
PAb to HIF-1 |
100 ug |
| BV-3643-100 |
PAb to Syndecan-1 |
100 ug |
| BV-3644-100 |
PAb to Syndecan-4 |
100 ug |
| BV-3644BP-50 |
Blocking Peptide for PAb to Syndecan-4 (BV-3644) |
50 ug |
| BV-3645-100 |
PAb to Decorin |
100 ug |
| BV-3646-100 |
MAb to His-Tag |
100 ug |
| BV-3647-100 |
PAb to ADH |
100 ug |
| BV-3648-100 |
PAb to Cyr61 |
100 ug |
| BV-3648BP-50 |
Blocking Peptide for PAb to Cyr61 (BV-3648) |
50 ug |
| BV-3649-100 |
PAb to Tyrosine Hydroxylase (activated) |
100 ul |
| BV-3650-100 |
PAb to MARCKS (activated) |
100 ul |
| BV-3651-100 |
PAb to DARPP-32 (activated) |
100 ul |
| BV-3653-100 |
PAb to Acetyl-Histone H2A |
100 ug |
| BV-3654-100 |
PAb to Acetyl-Histone H2B |
100 ug |
| BV-3655-100 |
PAb to Acetyl-Histone H3 |
100 ug |
| BV-3656-100 |
PAb to Acetyl-Histone H4 |
100 ug |
| BV-3657-100 |
PAb to Endothelial Lipase |
100 ug |
| BV-3657BP-50 |
Blocking Peptide for PAb to Endothelial Lipase (BV-3657) |
50 ug |
| BV-3658-100 |
PAb to Math1 |
100 ul |
| BV-3659-100 |
PAb to LOX-1 |
100 ul |
| BV-3661-100 |
PAb to ApoLipoprotein B |
100 ug |
| BV-3662-100 |
PAb to beta-Actin |
100 ug |
| BV-3662BP-50 |
Blocking Peptide for PAb to beta-Actin (BV-3662) |
50 ug |
| BV-3663-100 |
PAb to Beclin 1 |
100 ug |
| BV-3663BP-50 |
Blocking Peptide for PAb to Beclin 1 (BV-3663) |
50 ug |
| BV-3664-100 |
PAb to JIP 1 |
100 ug |
| BV-3664BP-50 |
Blocking Peptide for PAb to JIP 1 (BV-3664) |
50 ug |
| BV-3665-100 |
PAb to Noxa |
100 ug |
| BV-3665BP-50 |
Blocking Peptide for PAb to Noxa (BV-3665) |
50 ug |
| BV-3666-100 |
PAb to FKBP38 |
100 ug |
| BV-3666BP-50 |
Blocking Peptide for PAb to FKBP38 (BV-3666) |
50 ug |
| BV-3667-100 |
PAb to MST-1/Krs-2 |
100 ug |
| BV-3667BP-50 |
Blocking Peptide for PAb to MST-1/Krs-2 (BV-3667) |
50 ug |
| BV-3668-100 |
PAb to TEM-8 |
100 ug |
| BV-3668BP-50 |
Blocking Peptide for PAb to TEM-8 (BV-3668) |
50 ug |
| BV-3669-100 |
PAb to MMP-19 |
100 ug |
| BV-3670-100 |
PAb to Smad7 |
100 ug |
| BV-3671-100 |
PAb to Bcl-Rambo |
100 ug |
| BV-3671BP-50 |
Blocking Peptide for PAb to Bcl-Rambo (BV-3671) |
50 ug |
| BV-3672-100 |
PAb to Bin-1 |
100 ug |
| BV-3672BP-50 |
Blocking Peptide for PAb to Bin-1 (BV-3672) |
50 ug |
| BV-3673-100 |
PAb to FOXO3a |
100 ug |
| BV-3674-100 |
PAb to BRCA1 (activated) |
100 ug |
| BV-3675-100 |
PAb to BRCA2 |
100 ug |
| BV-3677-100 |
PAb to Hsp40 |
100 ug |
| BV-3678-100 |
PAb to FHIT |
100 ug |
| BV-3679-100 |
PAb to APS |
100 ug |
| BV-3680-100 |
PAb to YAP |
100 ug |
| BV-3681-100 |
PAb to RACK1 |
100 ug |
| BV-3682-100 |
PAb to TAB1 |
100 ug |
| BV-3683-100 |
PAb to MEF2A |
100 ug |
| BV-3684-100 |
PAb to Dvl3 |
100 ug |
| BV-3685-100 |
PAb to HTR2C (human) |
100 ug |
| BV-3686-100 |
PAb to PAK3 |
100 ug |
| BV-3686BP-50 |
Blocking Peptide for PAb to PAK3 (BV-3686) |
50 ug |
| BV-3687-100 |
PAb to COX-3 (mouse) |
100 ug |
| BV-3687BP-50 |
Blocking Peptide for PAb to COX-3 (mouse) (BV-3687) |
50 ug |
| BV-3688-100 |
PAb to HNF-4 |
100 ug |
| BV-3688BP-50 |
Blocking Peptide for PAb to HNF-4 (BV-3688) |
50 ug |
| BV-3689-100 |
PAb to HAT-1 |
100 ug |
| BV-3689BP-50 |
Blocking Peptide for PAb to HAT-1 (BV-3689) |
50 ug |
| BV-3690-100 |
PAb to SGLT-2 |
100 ug |
| BV-3690BP-50 |
Blocking Peptide for PAb to SGLT-2 (BV-3690) |
50 ug |
| BV-3691-100 |
PAb to HDC |
100 ug |
| BV-3691BP-50 |
Blocking Peptide for PAb to HDC (BV-3691) |
50 ug |
| BV-3692-100 |
PAb to HAT-2 |
100 ug |
| BV-3692BP-50 |
Blocking Peptide for PAb to HAT-2 (BV-3692) |
50 ug |
| BV-3693-100 |
PAb to NCS-1 |
100 ug |
| BV-3693BP-50 |
Blocking Peptide for PAb to NCS-1 (BV-3693) |
50 ug |
| BV-3694-100 |
PAb to MAP-1 |
100 ug |
| BV-3694BP-50 |
Blocking Peptide for PAb to MAP-1 (BV-3694) |
50 ug |
| BV-3695-100 |
PAb to Bcl-B (human) |
100 ug |
| BV-3695BP-50 |
Blocking Peptide for PAb to Bcl-B (BV-3695) |
50 ug |
| BV-3696-100 |
PAb to XAF-1 (human) |
100 ug |
| BV-3696BP-50 |
Blocking Peptide for PAb to XAF-1 (BV-3696) |
50 ug |
| BV-3697-100 |
PAb to Dicer |
100 ug |
| BV-3697BP-50 |
Blocking Peptide for PAb to Dicer (BV-3697) |
50 ug |
| BV-3698-100 |
PAb to MST-2/Krs-1 |
100 ug |
| BV-3698BP-50 |
Blocking Peptide for PAb to MST-2/Krs-1 (BV-3698) |
50 ug |
| BV-3699-100 |
PAb to TBLR1 (human) |
100 ug |
| BV-3699BP-50 |
Blocking Peptide for PAb to TBLR1 (human) (BV-3699) |
50 ug |
| BV-3700-100 |
PAb to Thromboxane B2 |
100 ug |
| BV-3700BP-50 |
Blocking Peptide for PAb to Thromboxane B2 (BV-3700) |
50 ug |
| BV-3701-100 |
PAb to JNK |
100 ug |
| BV-3702-100 |
PAb to c-Jun |
100 ug |
| BV-3703-100 |
PAb to BIK |
100 ug |
| BV-3703BP-50 |
Blocking Peptide for PAb to BIK (BV-3703) |
50 ug |
| BV-3704-100 |
PAb to BIF |
100 ug |
| BV-3704BP-50 |
Blocking Peptide for PAb to BIF (BV-3704) |
50 ug |
| BV-3705-100 |
PAb to TUCAN |
100 ug |
| BV-3705BP-50 |
Blocking Peptide for PAb to TUCAN (BV-3705) |
50 ug |
| BV-3706-100 |
PAb to Calsenilin |
100 ug |
| BV-3706BP-50 |
Blocking Peptide for PAb to Calsenilin (BV-3706) |
50 ug |
| BV-3707-100 |
PAb to HAT-3 (CT) |
100 ug |
| BV-3707BP-50 |
Blocking Peptide for PAb to HAT-3 (CT) (BV-3707) |
50 ug |
| BV-3708-100 |
PAb to Tubulin |
100 ug |
| BV-3709-100 |
PAb to FOXP3 |
100 ug |
| BV-3709BP-50 |
Blocking Peptide for PAb to FOXP3 (BV-3709) |
50 ug |
| BV-3710-100 |
PAb to PLCgamma 1&2 (human) |
100 ug |
| BV-3710BP-50 |
Blocking Peptide for PAb to PLCgamma 1&2 (human) (BV-3710) |
50 ug |
| BV-3711-100 |
PAb to SGLT-1 (human) |
100 ug |
| BV-3711BP-50 |
Blocking Peptide for Pab to SGLT-1 (human) (BV-3711) |
50 ug |
| BV-3712-100 |
PAb to Cathepsin V |
100 ug |
| BV-3712BP-50 |
Blocking Peptide for PAb to Cathepsin V (BV-3712) |
50 ug |
| BV-3713-100 |
PAb to c-Jun (activated)(pSer73) |
100 ug |
| BV-3714-100 |
PAb to LRP-5/6 |
100 ug |
| BV-3714BP-50 |
Blocking Peptide for PAb to LRP-5/6 (BV-3714) |
50 ug |
| BV-3732-100 |
PAb to MMP-12 |
100 ug |
| BV-3732BP-50 |
Blocking Peptide for PAb to MMP-12 (BV-3732) |
50 ug |
| BV-3733-100 |
PAb to Caper |
100 ul |
| BV-3734-100 |
PAb to CARM1 |
100 ul |
| BV-3735-100 |
PAb to CRSP1 |
100 ul |
| BV-3736-100 |
PAb to JLP |
100 ul |
| BV-3737-100 |
PAb to NIF1 |
100 ul |
| BV-3738-100 |
PAb to BRD8 |
100 ul |
| BV-3739-100 |
PAb to BRG1 |
100 ul |
| BV-3740-100 |
PAb to TOM40 |
100 ug |
| BV-3740BP-50 |
Blocking Peptide for PAb to TOM40 (BV-3740) |
50 ug |
| BV-3741-100 |
PAb to Cathepsin L (cleaved) |
100 ug |
| BV-3741BP-50 |
Blocking Peptide for PAb to Cathepsin L (cleaved) (BV-3741) |
50 ug |
| BV-3742-100 |
PAb to FoxL2 |
100 ug |
| BV-3742BP-50 |
Blocking Peptide for PAb to FoxL2 (BV-3742) |
50 ug |
| BV-3743-100 |
PAb to BTF |
100 ul |
| BV-3744-100 |
PAb to E6AP |
100 ul |
| BV-3745-100 |
PAb to FOXO1a (human) |
100 ul |
| BV-3746-100 |
PAb to SLK |
100 ul |
| BV-3747-100 |
PAb to SUP7 |
100 ul |
| BV-3748-100 |
PAb to PI-8 |
100 ug |
| BV-3748BP-50 |
Blocking Peptide for PAb to PI-8 (BV-3748) |
50 ug |
| BV-3749-100 |
PAb to 53BP1 |
100 ul |
| BV-3750-100 |
PAb to Nucleolin |
100 ul |
| BV-3751-100 |
PAb to NONO |
100 ul |
| BV-3752-100 |
PAb to Rad6 |
100 ul |
| BV-3753-100 |
PAb to RPA70 |
100 ul |
| BV-3754-100 |
PAb to SMC2 |
100 ul |
| BV-3755-100 |
PAb to TPX2 |
100 ul |
| BV-3756-100 |
PAb to VCP |
100 ul |
| BV-3757-100 |
PAb to XLF |
100 ul |
| BV-3758-100 |
PAb to MCM2 |
100 ul |
| BV-3759-100 |
PAb to MCAF |
100 ul |
| BV-3760-100 |
PAb to MCAK |
100 ul |
| BV-3761-100 |
PAb to Histone H2AX |
100 ul |
| BV-3762-100 |
PAb to HdmX/MDM4 |
100 ul |
| BV-3763-100 |
PAb to HEC1 |
100 ul |
| BV-3764-100 |
PAb to KAP-1 |
100 ul |
| BV-3765-100 |
PAb to MAD1 |
100 ul |
| BV-3766-100 |
PAb to MAD2 |
100 ul |
| BV-3767-100 |
PAb to ATR |
100 ul |
| BV-3768-100 |
PAb to BARD1 |
100 ul |
| BV-3769-100 |
PAb to BLM |
100 ul |
| BV-3770-100 |
PAb to Claspin |
100 ul |
| BV-3771-100 |
PAb to FUS |
100 ul |
| BV-3772-100 |
PAb to ASH2 |
100 ul |
| BV-3773-100 |
PAb to SRC3 |
100 ul |
| BV-3774-100 |
PAb to TIF1a/TRIM24 |
100 ul |
| BV-3775-100 |
PAb to TRIP1 |
100 ul |
| BV-3776-100 |
PAb to TAOK1 |
100 ul |
| BV-3777-100 |
PAb to GAPDH |
100 ul |
| BV-3778-100 |
PAb to CSE1 |
100 ul |
| BV-3779-100 |
PAb to RCH1 |
100 ul |
| BV-3780-100 |
PAb to SRA |
100 ul |
| BV-3781-100 |
PAb to TPR |
100 ul |
| BV-3782-100 |
PAb to EGFR |
100 ul |
| BV-3783-100 |
PAb to ErbB2 |
100 ul |
| BV-3784-100 |
PAb to JIK |
100 ul |
| BV-3785-100 |
PAb to LOK |
100 ul |
| BV-3786-100 |
PAb to mTOR |
100 ul |
| BV-3787-100 |
PAb to PIM1 |
100 ul |
| BV-3788-100 |
PAb to PKD2 |
100 ul |
| BV-3789-100 |
PAb to Rho Kinase alpha |
100 ul |
| BV-3790-100 |
PAb to Rho Kinase beta |
100 ul |
| BV-3791-100 |
PAb to ZBTB7 |
100 ul |
| BV-3792-100 |
PAb to PRMT1 |
100 ul |
| BV-3793-100 |
PAb to RbBP5 |
100 ul |
| BV-3794-100 |
PAb to REA |
100 ul |
| BV-3795-100 |
PAb to Rtf1 |
100 ul |
| BV-3796-100 |
PAb to CTBP1 |
100 ul |
| BV-3797-100 |
PAb to Menin |
100 ul |
| BV-3798-100 |
PAb to MLL1 |
100 ul |
| BV-3799-100 |
PAb to MTA1 |
100 ul |
| BV-3800-100 |
PAb to Paf1 |
100 ul |
| BV-3801-100 |
MAb to LRP-5/6 (1A12) |
100 ug |
| BV-3801BP-50 |
Blocking Peptide for MAb to LRP-5/6 (1A12) (BV-3801) |
50 ug |
| BV-3802-100 |
MAb to DKK2 |
100 ug |
| BV-3803-100 |
MAb to GAPDH (BV-1D4) |
100 ug |
| BV-3994-100 |
MAb to Red Fluorescence Protein (BV-F9) |
100 ug |
| BV-3995-100 |
PAb to Myc-Tag |
100 ug |
| BV-3995BP-50 |
Blocking Peptide for PAb to Myc-Tag (BV-3995) |
50 ug |
| BV-3996-200 |
MAb to HA-Tag |
200 ug |
| BV-3996B-100 |
MAb to HA-Tag (Biotin) |
100 ug |
| BV-3996F-100 |
MAb to HA-Tag (FITC) |
100 ug |
| BV-3997-100 |
PAb to GST-Tag |
100 ug |
| BV-3998-100 |
PAb to His-Tag |
100 ug |
| BV-3998BP-50 |
Blocking Peptide for PAb to His-Tag (BV-3998) |
50 ug |
| BV-3999-100 |
PAb to GFP |
100 ug |
